| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | $238.46 | $96.05B | N/A |
Thermo Fisher Scientific (TMO) Tops Q4 Earnings and Revenue Estimates
http://www.zacks.com/stock/news/350585/thermo-fisher-scientific-tmo-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-350585
Jan 30, 2019 - Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.88% and 4.32%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
0
Top Research Reports for Amazon, Berkshire Hathaway & Thermo Fisher
http://www.zacks.com/research-daily/218591/top-research-reports-for-amazon-berkshire-hathaway-thermo-fisher?cid=CS-ZC-FT-218591
Mar 07, 2019 - Top Research Reports for Amazon, Berkshire Hathaway & Thermo Fisher
0
Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip
http://www.zacks.com/stock/news/364388/thermo-fisher-to-buy-brammer-bio-tightens-gene-therapy-grip?cid=CS-ZC-FT-364388
Mar 25, 2019 - On closure of the acquisition deal, Brammer Bio will be integral to Thermo Fisher's (TMO) pharma services business within its Laboratory Products and Services wing.
0
Thermo Fisher (TMO) Hits 52-Week High, Can the Run Continue?
http://www.zacks.com/stock/news/376826/thermo-fisher-tmo-hits-52-week-high-can-the-run-continue?cid=CS-ZC-FT-376826
Apr 10, 2019 - Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
0
TMO or ABMD: Which Is the Better Value Stock Right Now?
http://www.zacks.com/stock/news/388982/tmo-or-abmd-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-388982
Apr 19, 2019 - TMO vs. ABMD: Which Stock Is the Better Value Option?
0
Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site
http://www.zacks.com/stock/news/415702/thermo-fisher-acquires-glaxosmithklines-drug-production-site?cid=CS-ZC-FT-415702
May 17, 2019 - The latest acquisition aligns with Thermo Fisher's (TMO) strategy of enhancing capabilities of its Pharma Services through the right balance of capital investment, and merger and acquisition.
0